ACRF Comprehensive Cancer Genomics Facility

ACRF’s funding saw the creation of a unique, integrated genetics and genomics facility on the Princess Alexandra Hospital campus, aiming to boost and integrate cancer gene discovery, gene characterisation and translation to clinical practice. Professor Ian Frazer, whose research led to the development of the cervical cancer vaccine, conducted a major research program on cervical cancer genetics utilising the resources of the ACRF Comprehensive Cancer Genomics Facility. Advances in genomics and genetics revolutionised our understanding of cancer and led to the identification of new therapeutic targets and biomarkers. ACRF’s grant funded a wide range of unique state of the art equipment and clinical material collections, establishing a fully integrated genomics facility which, in turn, provided novel insights into a number of important cancer types. Director of Research: Professor Tom Gonda, Senior Researchers: Professor Ian Frazer and Professor Colleen Nelson